Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Burden of Illness in Chronic Graft vs. Host Disease - A Prospective Cohort Study.

Iskra Pusic, MD, John Dickinson, MD, PhD, Seth Steinberg, PhD, Jeanne Odom, RN, Niveen Atlam, Sandra Mitchell, RN, NP, Daniele Avila, RN, NP, Michael Krumlauf, RN, Kristin Baird, MD, Steven Pavletic, MD

Blood (2007) 110 (11): 1667.

https://doi.org/10.1182/blood.V110.11.1667.1667

Published: 2007

Journal Articles

Ex-Vivo Reduction of Allograft T Cell Dose Does Not Prevent Acute Graft-vs-Host Disease after Reduced-Intensity Hematopoietic Stem Cell Transplantation.

Nancy M. Hardy, MD, Frances Hakim, PhD, Seth Steinberg, PhD, Michael Krumlauf, Rebecca Babb, Jeanne Odom, Daniel Fowler, MD, Ronald Gress, MD, Michael R. Bishop, MD

Blood (2006) 108 (11): 2871.

https://doi.org/10.1182/blood.V108.11.2871.2871

Published: 2006

Journal Articles

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Claude Sportes, MD, Michael Krumlauf, RN, Rebecca Babb, RN, Ladan Foruraghi, RN, Janine Daub, RN, Daniele Avila, RN, Catherine Chow, MD, Hua Zhang, PhD, Kevin Chua, PhD, Terry Fry, MD, Sarfraz Memon, PhD, Frances Hakim, PhD, Thomas Fleisher, MD, Margaret Brown, BSN, Julie Engel, PhD, Renaud Buffet, MD, Michel Morre, DVM, Ronald Gress, MD, Crystal Mackall, MD

Blood (2006) 108 (11): 871.

https://doi.org/10.1182/blood.V108.11.871.871

Published: 2006

Journal Articles

Allograft T Cell Content Influences Early Engraftment after Reduced-Intensity Stem Cell Transplantation (RIST).

Robert M. Dean, MD, Daniel H. Fowler, MD, Nancy M. Hardy, MD, Jeanne Odom, RN, Kathleen Castro, MSN, Michael Krumlauf, RN, Frances T. Hakim, PhD, Claude Sportes, MD, Ronald E. Gress, MD, Michael R. Bishop

Blood (2005) 106 (11): 3662.

https://doi.org/10.1182/blood.V106.11.3662.3662

Published: 2005

Journal Articles

Preliminary Results of Sibling Donor Immunization with Patient-Derived Id-KLH Vaccine Prior to Reduced-Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma.

Michael R. Bishop, MD, Sattva Neelapu, MD, Daniel H. Fowler, Michael Krumlauf, RN, Ronald Gress, MD, Larry W. Kwak, MD, PhD

Blood (2004) 104 (11): 814.

https://doi.org/10.1182/blood.V104.11.814.814

Published: 2004

Journal Articles

Engraftment Syndrome after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Graft-Versus-Host Disease Prophylaxis and T Cell Dose.

Robert M. Dean, MD, Kyle M. Donley, BA, Juan Gea-Banacloche, MD, Seth M. Steinberg, PhD, Jeanne Odom, RN, Michael Krumlauf, RN, Kathleen Castro, RN, Tracey Chinn, RN, Daniel H. Fowler, MD, Ronald E. Gress, MD, Michael R. Bishop, MD

Blood (2004) 104 (11): 5052.

https://doi.org/10.1182/blood.V104.11.5052.5052

Published: 2004

Journal Articles

Immunotherapy and Chemotherapy Can Result in Long-Term Survival for Patients with Recurrent or Progressive Non-Hodgkin’s Lymphoma after Reduced-Intensity Allogeneic Stem Cell Transplantation.

Michael R. Bishop, MD, Robert M. Dean, MD, Wyndham H. Wilson, MD, PhD, Jeanne Odom, RN, Seth Steinberg, PhD, Michael Krumlauf, RN, Claude Kasten-Sportes, MD, Steven Z. Pavletic, MD, Kathleen Castro, RN, Tracey Chinn, RN, Ronald Gress, MD, Daniel H. Fowler, MD

Blood (2004) 104 (11): 1643.

https://doi.org/10.1182/blood.V104.11.1643.1643

Published: 2004

NARROW

Burden of Illness in Chronic Graft vs. Host Disease - A Prospective Cohort Study.

Ex-Vivo Reduction of Allograft T Cell Dose Does Not Prevent Acute Graft-vs-Host Disease after Reduced-Intensity Hematopoietic Stem Cell Transplantation.

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Allograft T Cell Content Influences Early Engraftment after Reduced-Intensity Stem Cell Transplantation (RIST).

Preliminary Results of Sibling Donor Immunization with Patient-Derived Id-KLH Vaccine Prior to Reduced-Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma.

Engraftment Syndrome after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Graft-Versus-Host Disease Prophylaxis and T Cell Dose.

Immunotherapy and Chemotherapy Can Result in Long-Term Survival for Patients with Recurrent or Progressive Non-Hodgkin’s Lymphoma after Reduced-Intensity Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Burden of Illness in Chronic Graft vs. Host Disease - A Prospective Cohort Study.

Ex-Vivo Reduction of Allograft T Cell Dose Does Not Prevent Acute Graft-vs-Host Disease after Reduced-Intensity Hematopoietic Stem Cell Transplantation.

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Allograft T Cell Content Influences Early Engraftment after Reduced-Intensity Stem Cell Transplantation (RIST).

Preliminary Results of Sibling Donor Immunization with Patient-Derived Id-KLH Vaccine Prior to Reduced-Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma.

Engraftment Syndrome after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Graft-Versus-Host Disease Prophylaxis and T Cell Dose.

Immunotherapy and Chemotherapy Can Result in Long-Term Survival for Patients with Recurrent or Progressive Non-Hodgkin’s Lymphoma after Reduced-Intensity Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only